Erick Wayne DeVinney - 15 Dec 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: VP Peripheral Nerve Science
Signature: /s/Erick DeVinney
Issuer symbol: AXGN
Transactions as of: 15 Dec 2021
Net transactions value: -$4.8
Form type: 4
Filing time: 17 Dec 2021, 15:02:34 UTC
Previous filing: 21 Jul 2021
Next filing: 22 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$36,700	+10,000	+12%	$3.67	90,426	15 Dec 2021	Direct	F1
transaction	AXGN	Common Stock	Tax liability	$36,705	-4,171	-4.6%	$8.80	86,255	15 Dec 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Employee Stock Option (right to buy)	Options Exercise	$0	-10,000	-100%	$0.000000^*	0	15 Dec 2021	Common Stock	10,000	$3.67	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This reflects the number of shares that became vested as of December 29, 2018.
F2	Represents the number of shares swapped to cover the exercise price of the options exercised via an attestation method stock swap in accordance with Rule16b-3.